Source: Annual Congress 2004 - Modern techniques bringing new insights into cystic fibrosis
Disease area: Respiratory infections



Rating:

Share or cite this content

Citations should be made in the following way:
J. Mainz, K. Dawczynski, A. Huebler, P. Nardella, D. van Devanter, F. Zintl (Jena, Germany; Seattle, United States Of America). Is the analysis of torbamycin in exhaled breath condensate a diagnostic tool to monitor pulmonary drug deposition?. Eur Respir J 2004; 24: Suppl. 48, 2396

Member's Comments

No comment yet.

Related content which might interest you: Exhaled breath condensate - a new tool for assessment of idiopathic pulmonary fibrosis? Source: International Congress 2018 – News on the diagnosis of idiopathic interstitial pneumonia Year: 2018 Better characterization of local inflammation in COPD: detection of new biomarkers in exhaled breath condensate Source: Eur Respir J 2006; 28: Suppl. 50, 747s Year: 2006 Exhaled breath analysis by use of eNose technology: a novel diagnostic tool for interstitial lung disease Source: Eur Respir J, 57 (1) 2002042; 10.1183/13993003.02042-2020 Year: 2021 Lung disease diagnostic method based on proteomic analysis of exhaled breath condensate Source: International Congress 2019 – Basic research of airway diseases Year: 2019 The validation of assays used to measure biomarkers in exhaled breath condensate Source: Eur Respir J 2008; 32: 1408-1409 Year: 2008 Metabolomic/proteomic analysis of biomarkers in exhaled breath condensates Source: Annual Congress 2008 - PG8 - Cellular and molecular technologies of today - treatments of tomorrow Year: 2008 Measuring exhaled NO and breath condensate: where do we stand? Source: Annual Congress 2006 - PG14 - Noninvasive monitoring of asthma inflammation and treatment Year: 2006 Exhaled breath condensate sample collection: standards and open issues Source: Eur Respir Monogr 2010; 49: 152-161 Year: 2010 Exhaled breath condensate biomarkers in COPD Source: Eur Respir J 2008; 32: 472-486 Year: 2008 Is exhaled breath temperature a useful marker of pulmonary inflammation? Source: Annual Congress 2008 - Investigation, inspiration, ventilation, dedication: the essence of physiological measurement Year: 2008 Is the collecting of the exhaled breath condensate a burden for the patient? Source: Eur Respir J 2004; 24: Suppl. 48, 283s Year: 2004 Exhaled breath condensate pH standardised for CO2 partial pressure Source: Eur Respir J 2007; 29: 496-501 Year: 2007 Prediction of CF exacerbations by FeNO and non-invasive inflammatory markers in exhaled breath condensate Source: Annual Congress 2008 - Cystic fibrosis: novel aspects of airway function and inflammation Year: 2008 Semi-volatile organic compounds in exhaled breath condensate: a new approach in the differential diagnosis of asthma and COPD Source: Annual Congress 2009 - Asthma assessment and original therapeutic approaches Year: 2009 Separate lung exhaled breath condensate collection confirms intrapulmonary origin of exhaled breath condensate acidification Source: Eur Respir J 2007; 30: Suppl. 51, 364s Year: 2007 Breath condenser coatings affect measurement of biomarkers in exhaled breath condensate Source: Eur Respir J 2006; 28: 1036-1041 Year: 2006 Diagnosis of lung diseases based on proteomic analysis of exhaled breath condensate Source: International Congress 2017 – Clinical problems in lung diseases Year: 2017